top of page

Can Psychedelics Be The New Antidepressants?




While psychedelics have been the subject of stigma for many decades, renewed research and interest in this space is rocking the world of psychiatry by offering new effective breakthrough therapies for the treatment of depression amongst a list of other common mental health disorders.


The Scientific American recently published a comprehensive article exploring the growing evidence and use of psychedelics as antidepressants.

"As far as outcomes go, psychedelics in combination with psychotherapy are remarkably efficient at treating depression. Compared to selective serotonin reuptake inhibitors, or SSRIs, the current gold standard in antidepressant medication, psychedelics have a faster effect on patients, sometimes effective with only a single therapy session. On the other hand, anti-depressants often take weeks before a reversal of depression is observed."


"Psychedelics also have a longer-lasting effect than an SSRI regimen. A 2015 study of more than 190,000 Americans demonstrated that past history of psychedelic use decreases the odds of suicidal thoughts or actions over the course of a lifetime, whereas a history of other drug use (such as sedatives or inhalants) increases these risks."



anahita-olive-dress-portrait.png

About the Author

 Anahita Anais is a nervous system expert and the founder of MicrodoseGuru, bringing two decades of experience in somatic healing, ceremonial work, and psychedelic science to her research and writing. Her work translates emerging clinical evidence on microdosing into practical, rigorous guidance for people navigating depression, anxiety, ADHD, and psychiatric medication transitions.

New to microdosing? Start here.

A free 33-page guide on what microdosing is, how it works, and how to begin without the guesswork.
bottom of page